Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
54
JNJ Quote, Financials, Valuation and Earnings
Last price:
$207.26
Seasonality move
:
2.29%
Day range:
$205.50 - $208.08
52-week range:
$140.68 - $215.19
Dividend yield:
2.48%
P/E ratio:
20.01x
P/S ratio:
5.46x
P/B ratio:
6.30x
Volume:
8.2M
Avg. volume:
9.8M
1-year change:
43.5%
Market cap:
$499.5B
Revenue:
$88.8B
EPS (TTM):
$10.36
Analysts' Opinion
-
Consensus RatingJohnson & Johnson has received a consensus rating of Hold. The company's average rating is a Hold based on 9 Buy ratings, 11 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $209.29, Johnson & Johnson has an estimated upside of 0.95% from its current price of $207.32.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $155.00 representing 100% downside risk from its current price of $207.32.
Fair Value
-
According to the consensus of 20 analysts, Johnson & Johnson has 0.95% upside to fair value with a price target of $209.29 per share.
JNJ vs. S&P 500
-
Over the past 5 trading days, Johnson & Johnson has underperformed the S&P 500 by -5.41% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Johnson & Johnson does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Johnson & Johnson has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Johnson & Johnson reported revenues of $24B.
Earnings Growth
-
Johnson & Johnson has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Johnson & Johnson reported earnings per share of $2.12.
Enterprise value:
526.7B
EV / Invested capital:
4.21x
Price / LTM sales:
5.46x
EV / EBIT:
22.17x
EV / Revenue:
5.72x
PEG ratio (5yr expected):
0.28x
EV / Free cash flow:
25.74x
Price / Operating cash flow:
24.57x
Enterprise value / EBITDA:
16.91x
Gross Profit (TTM):
$62.9B
Return On Assets:
13.39%
Net Income Margin (TTM):
27.26%
Return On Equity:
33.27%
Return On Invested Capital:
20.94%
Operating Margin:
29.64%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $83.7B | $87.7B | $92.1B | $22.5B | $24B | |
| Gross Profit | $58.2B | $60.2B | $62.9B | $15.5B | $16.7B | |
| Operating Income | $22.8B | $21.6B | $23.8B | $5.1B | $7.1B | |
| EBITDA | $30.1B | $28.9B | $31.2B | $7B | $8.9B | |
| Diluted EPS | $5.24 | $6.05 | $10.36 | $1.11 | $2.12 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $59.9B | $65.2B | $53.7B | $53.2B | $54.6B | |
| Total Assets | $179.2B | $175.1B | $166.1B | $178.3B | $192.8B | |
| Current Liabilities | $44.6B | $45.5B | $44.4B | $51.8B | $50.9B | |
| Total Liabilities | $109B | $100.5B | $94.8B | $108.1B | $113.5B | |
| Total Equity | $70.3B | $74.6B | $71.2B | $70.2B | $79.3B | |
| Total Debt | $30.1B | $27.6B | $26.1B | $31.3B | $39.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $20.3B | $25.1B | $24.2B | $8B | $9.2B | |
| Cash From Investing | -$2.3B | -$18.5B | -$20.4B | -$3.1B | -$542M | |
| Cash From Financing | -$9.5B | -$6.4B | -$5.5B | -$9.9B | -$8.9B | |
| Free Cash Flow | $15.7B | $19.5B | $20.5B | $5.7B | $8B | |
JNJ
Sector
Market Cap
$499.5B
$28.4M
Price % of 52-Week High
96.35%
51.17%
Dividend Yield
2.48%
0%
Shareholder Yield
3.08%
-1.49%
1-Year Price Total Return
43.5%
-16.67%
Beta (5-Year)
0.357
0.518
Dividend yield:
2.48%
Annualized payout:
$4.91
Payout ratio:
61.28%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$209.67
200-day SMA
Buy
Level
$172.63
Bollinger Bands (100)
Buy
Level
176.08 - 200.32
Chaikin Money Flow
Buy
Level
2.1B
20-day SMA
Buy
Level
$206.66
Relative Strength Index (RSI14)
Buy
Level
56.78
ADX Line
Buy
Level
33.72
Williams %R
Neutral
Level
-51.4725
50-day SMA
Buy
Level
$198.08
MACD (12, 26)
Buy
Level
3.14
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
989.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.0457)
Buy
CA Score
(Annual)
Level (-0.1681)
Buy
Beneish M-Score
(Annual)
Level (-2.7278)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.4297)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Stock Forecast FAQ
In the current month, JNJ has received 9 Buy ratings 11 Hold ratings, and 0 Sell ratings. The JNJ average analyst price target in the past 3 months is $209.29.
-
Where Will Johnson & Johnson Stock Be In 1 Year?
According to analysts, the consensus estimate is that Johnson & Johnson share price will rise to $209.29 per share over the next 12 months.
-
What Do Analysts Say About Johnson & Johnson?
Analysts are divided on their view about Johnson & Johnson share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Johnson & Johnson is a Sell and believe this share price will drop from its current level to $155.00.
-
What Is Johnson & Johnson's Price Target?
The price target for Johnson & Johnson over the next 1-year time period is forecast to be $209.29 according to 20 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is JNJ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Johnson & Johnson is a Hold. 11 of 20 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of JNJ?
You can purchase shares of Johnson & Johnson via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Johnson & Johnson shares.
-
What Is The Johnson & Johnson Share Price Today?
Johnson & Johnson was last trading at $207.26 per share. This represents the most recent stock quote for Johnson & Johnson. Yesterday, Johnson & Johnson closed at $207.32 per share.
-
How To Buy Johnson & Johnson Stock Online?
In order to purchase Johnson & Johnson stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get JNJ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
JNJ
Sector
P/E ratio
20.01x
23.89x
PEG ratio
0.28x
-0.01x
P/B ratio
6.30x
1.81x
Price / LTM sales
5.46x
1.58x
Growth Metrics
JNJ
Sector
Revenue growth
6.77%
4.62%
Earnings growth
91.19%
10.7%
Revenue (5-year growth)
1.58%
6.5%
Earnings forecast
$2.76
-$0.21
Profitability
JNJ
Sector
Profitability FY 2024
$61B
$3.6M
Return on invested capital
20.94%
-31.84%
Return on assets
13.39%
-27.96%
Return on equity
33.27%
-37.63%
Earnings Date
Last Earnings Date
Oct
14
Next Earnings Date
Jan
21
Estimated Next Earnings Date
Jan
13
Balance Sheet
JNJ
Sector
Total cash
$18.6B
$26.4M
Short term investments
$417M
$25.7M
Total assets
$180.1B
$76.9M
Long term debt
$39.4B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 5.38% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is up 1.37% over the past day.
Buy
69
QBTS alert for Dec 23
D-Wave Quantum, Inc. [QBTS] is down 3.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
